minoxidil has been researched along with Dermatitis Seborrheica in 2 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare topical minoxidil 2% and cyproterone acetate in the treatment of female alopecia." | 9.10 | Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. ( Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Jouanique, C; Reygagne, P; Vexiau, P, 2002) |
| "To compare topical minoxidil 2% and cyproterone acetate in the treatment of female alopecia." | 5.10 | Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. ( Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Jouanique, C; Reygagne, P; Vexiau, P, 2002) |
| "The paper reports the results of local treatment using minoxidil 2% in a watery solution at a dose of 2 ml/day in 50 patients affected by androgenetic alopecia." | 5.06 | [Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia]. ( Pinelli, S; Rigoni, C; Scarabelli, G; Terenzio, C; Toffolo, P, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vexiau, P | 1 |
| Chaspoux, C | 1 |
| Boudou, P | 1 |
| Fiet, J | 1 |
| Jouanique, C | 1 |
| Hardy, N | 1 |
| Reygagne, P | 1 |
| Rigoni, C | 1 |
| Pinelli, S | 1 |
| Toffolo, P | 1 |
| Scarabelli, G | 1 |
| Terenzio, C | 1 |
2 trials available for minoxidil and Dermatitis Seborrheica
| Article | Year |
|---|---|
Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Topics: Administration, Topical; Adult; Alopecia; Androgen Antagonists; Body Mass Index; Contraceptives, Ora | 2002 |
[Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia].
Topics: Adolescent; Adult; Alopecia; Dermatitis, Seborrheic; Drug Tolerance; Female; Humans; Male; Middle Ag | 1990 |